Where does MDXH stock trade?

MDxHealth SA (MDXH) is listed on NASDAQ.

What sector and industry is MDXH in?

MDxHealth SA operates in the Health Care sector, Medical Specialities industry.

When did MDxHealth SA go public?

MDxHealth SA (MDXH) completed its IPO in 2021.

What are analysts saying about MDXH?

MDxHealth SA has had 5 recent analyst actions on file. The most recent action was from William Blair: Mkt Perform on 2026-05-14. Recent price targets range from $700.00 to $1800.00.

What companies are similar to MDXH?

Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.). Compare MDXH side-by-side with any of them on Quantisnow.

How can I track MDXH on Quantisnow?

Quantisnow aggregates MDxHealth SA's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MDXH to receive live email and push alerts on every new disclosure.

MDXH

NASDAQ

MDxHealth SA

SectorHealth CareIndustryMedical SpecialitiesIPO2021

Follow Website

News25/Ratings5

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

News · 26 weeks44+125%

2026-03-012026-08-23

Mix2690d

Insider11(42%)
Other8(31%)
SEC Filings5(19%)
Earnings2(8%)

Latest news

25 items

MDXH FAQ

7 questions

What does MDxHealth SA do?
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth...
Where does MDXH stock trade?
MDxHealth SA (MDXH) is listed on NASDAQ.
What sector and industry is MDXH in?
MDxHealth SA operates in the Health Care sector, Medical Specialities industry.
When did MDxHealth SA go public?
MDxHealth SA (MDXH) completed its IPO in 2021.
What are analysts saying about MDXH?
MDxHealth SA has had 5 recent analyst actions on file. The most recent action was from William Blair: Mkt Perform on 2026-05-14. Recent price targets range from $700.00 to $1800.00.
What companies are similar to MDXH?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.). Compare MDXH side-by-side with any of them on Quantisnow.
How can I track MDXH on Quantisnow?
Quantisnow aggregates MDxHealth SA's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MDXH to receive live email and push alerts on every new disclosure.